Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Peer Christiansen"'
Autor:
Buket Öztürk Esen, Rikke Nørgaard Pedersen, Deirdre Cronin-Fenton, Lene Mellemkjær, Timothy L. Lash, Bent Ejlertsen, Peer Christiansen, Mette Nørgaard
Publikováno v:
J Natl Cancer Inst
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Background Extended, more effective breast cancer treatments have increased the prevalence of long-term survivors. We investigated the risk of late breast cancer recurrence (BCR), 10 years or more after primary diagnosis, and associations between pat
Autor:
M.T.F.D. Vrancken Peeters, R.A.E.M. Tollenaar, E. Heeg, M.B. Jensen, Peer Christiansen, Bent Ejlertsen, Marc A.M. Mureau
Publikováno v:
Breast Cancer Research and Treatment, 182(3), 709-718. SPRINGER
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Purpose Breast-contour preservation (BCP) is possible for most women treated for early-stage breast cancer. BCP can be defined as primary breast-conserving treatment (BCT), neoadjuvant chemotherapy (NAC) followed by BCT and immediate postmastectomy b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38648ffb3e234e8a674854b52cd34809
https://link.springer.com/article/10.1007/s10549-020-05725-z
https://link.springer.com/article/10.1007/s10549-020-05725-z
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Helene Tilma Vistisen, Henrik A Kolstad, Peer Christiansen, Morten Frydenberg, Johnni Hansen, Anne Helene Garde, Åse Marie Hansen, Jens Peter Bonde
Publikováno v:
Vistisen, H T, Garde, A H, Frydenberg, M, Christiansen, P, Hansen, Å M, Hansen, J, Bonde, J P E & Kolstad, H A 2017, ' Short-term effects of night shift work on breast cancer risk; a cohort study of payroll data ', Scandinavian Journal of Work, Environment & Health, vol. 43, no. 1, pp. 59-67 . https://doi.org/10.5271/sjweh.3603
Scandinavian Journal of Work, Environment & Health, Vol 43, Iss 1, Pp 59-67 (2017)
Vistisen, H T, Garde, A H, Frydenberg, M, Christiansen, P, Hansen, Å M, Hansen, J, Bonde, J P E & Kolstad, H A 2017, ' Short-term effects of night shift work on breast cancer risk : a cohort study of payroll data ', Scandinavian Journal of Work, Environment & Health, vol. 43, no. 1, pp. 59-67 . https://doi.org/10.5271/sjweh.3603
Scandinavian Journal of Work, Environment & Health, Vol 43, Iss 1, Pp 59-67 (2017)
Vistisen, H T, Garde, A H, Frydenberg, M, Christiansen, P, Hansen, Å M, Hansen, J, Bonde, J P E & Kolstad, H A 2017, ' Short-term effects of night shift work on breast cancer risk : a cohort study of payroll data ', Scandinavian Journal of Work, Environment & Health, vol. 43, no. 1, pp. 59-67 . https://doi.org/10.5271/sjweh.3603
Objectives: The objective was to examine if night shift work is a short-term risk factor for breast cancer, including combined estrogen receptor (ER) and human epidermal growth factor 2 (HER2) breast cancer subtypes. Methods: The cohort comprised 155
Publikováno v:
Clinical Epidemiology
Christiansen, P, Ejlertsen, B, Jensen, M-B & Mouridsen, H 2016, ' Danish Breast Cancer Cooperative Group ', Clinical epidemiology, vol. 8, pp. 445-449 . https://doi.org/10.2147/CLEP.S99457
Christiansen, P, Ejlertsen, B, Jensen, M-B & Mouridsen, H 2016, ' Danish Breast Cancer Cooperative Group ', Clinical epidemiology, vol. 8, pp. 445-449 . https://doi.org/10.2147/CLEP.S99457
AIM OF DATABASE: Danish Breast Cancer Cooperative Group (DBCG), with an associated database, was introduced as a nationwide multidisciplinary group in 1977 with the ultimate aim to improve the prognosis in breast cancer. Since then, the database has
Autor:
Gitte Bjørn Hvilsom, Christoffer Holst Hahn, Katalin Kiss, Henrik Baymler Pedersen, Christian Godballe, Stefano Christian Londero, Marie Louise Jespersen, Giedrius Lelkaitis, Sten Schytte, Peer Christiansen, Stine Rosenkilde Larsen
Publikováno v:
Hvilsom, G B, Londero, S C, Hahn, C H, Schytte, S, Pedersen, H B, Christiansen, P, Kiss, K, Larsen, S R, Jespersen, M L, Lelkaitis, G & Godballe, C 2018, ' Anaplastic thyroid carcinoma in Denmark 1996-2012 : A national prospective study of 219 patients ', Cancer epidemiology, vol. 53, pp. 65-71 . https://doi.org/10.1016/j.canep.2018.01.011
Hvilsom, G B, Londero, S C, Hahn, C H, Schytte, S, Pedersen, H B, Christiansen, P, Kiss, K, Larsen, S R, Jespersen, M L, Lelkaitis, G & Godballe, C 2018, ' Anaplastic thyroid carcinoma in Denmark 1996-2012 : A national prospective study of 219 patients ', Cancer Epidemiology, vol. 53, pp. 65-71 . https://doi.org/10.1016/j.canep.2018.01.011
Hvilsom, G B, Londero, S C, Hahn, C H, Schytte, S, Pedersen, H B, Christiansen, P, Kiss, K, Larsen, S R, Jespersen, M L, Lelkaitis, G & Godballe, C 2018, ' Anaplastic thyroid carcinoma in Denmark 1996-2012 : A national prospective study of 219 patients ', Cancer Epidemiology, vol. 53, pp. 65-71 . https://doi.org/10.1016/j.canep.2018.01.011
BACKGROUND: Anaplastic thyroid carcinoma (ATC) is the least common but most malignant thyroid cancer. We aimed to examine the characteristics as well as evaluate the incidence, prognostic factors, and if introduction of a fast track cancer program mi
Autor:
Timothy L. Lash, Peer Christiansen, Lone Winther Lietzen, Deirdre Cronin-Fenton, Henrik Toft Sørensen
Publikováno v:
Lietzen, L W, Cronin-Fenton, D, Christiansen, P, Sørensen, H T & Lash, T L 2015, ' Autoimmune diseases and breast cancer recurrence : a Danish nationwide cohort study ', Breast Cancer Research and Treatment . https://doi.org/10.1007/s10549-014-3258-2
Autoimmune diseases (ADs) comprise a large group of heterogeneous diseases in which the immune system attacks healthy organs. Both intrinsic changes in the body and AD treatment can compromise immune function. Impaired immune function could increase
Publikováno v:
Ahern, T P, Lash, T L, Damkier, P, Christiansen, P M & Cronin-Fenton, D P 2014, ' Statins and breast cancer prognosis : evidence and opportunities ', Lancet Oncology, vol. 15, no. 10, pp. e461-8 . https://doi.org/10.1016/S1470-2045(14)70119-6
Ahern, T P, Lash, T L, Damkier, P, Christiansen, P M & Cronin-Fenton, D P 2014, ' Statins and breast cancer prognosis : evidence and opportunities ', Lancet Oncology, vol. 15, no. 10, pp. E461-E468 . https://doi.org/10.1016/S1470-2045(14)70119-6
Ahern, T P, Lash, T L, Damkier, P, Christiansen, P M & Cronin-Fenton, D P 2014, ' Statins and breast cancer prognosis : evidence and opportunities ', Lancet Oncology, vol. 15, no. 10, pp. E461-E468 . https://doi.org/10.1016/S1470-2045(14)70119-6
Much preclinical and epidemiological evidence supports the anticancer effects of statins. Epidemiological evidence does not suggest an association between statin use and reduced incidence of breast cancer, but does support a protective effect of stat
Autor:
Peer Christiansen, Åse Marie Hansen, Henrik A Kolstad, Anne Helene Garde, Helene Tilma Vistisen, Morten Frydenberg, Bonde Jpe
Publikováno v:
Kolstad, H A, Garde, A H, Hansen, Å M, Frydenberg, M, Christiansen, P, Vistisen, H T & Bonde, J P E 2017, ' Response to Dr Stevens' letter ref. Visitisen et al: "Short-term effects of night shift work on breast cancer risk: a cohort study of payroll data" ', Scandinavian Journal of Work, Environment & Health, vol. 43, no. 1, pp. 96 . https://doi.org/10.5271/sjweh.3609
Kolstad, H A, Garde, A H, Hansen, Å M, Frydenberg, M, Christiansen, P, Vistisen, H T & Bonde, J P E 2017, ' Response to Dr Stevens' letter ref. Visitisen et al : "Short-term effects of night shift work on breast cancer risk: a cohort study of payroll data" ', Scandinavian Journal of Work, Environment & Health, vol. 43, no. 1, pp. 96-96 . https://doi.org/10.5271/sjweh.3609
Scandinavian Journal of Work, Environment & Health, Vol 43, Iss 1, Pp 96-96 (2017)
Kolstad, H A, Garde, A H, Hansen, Å M, Frydenberg, M, Christiansen, P, Vistisen, H T & Bonde, J P E 2017, ' Response to Dr Stevens' letter ref. Visitisen et al : "Short-term effects of night shift work on breast cancer risk: a cohort study of payroll data" ', Scandinavian Journal of Work, Environment & Health, vol. 43, no. 1, pp. 96-96 . https://doi.org/10.5271/sjweh.3609
Scandinavian Journal of Work, Environment & Health, Vol 43, Iss 1, Pp 96-96 (2017)
We thank Dr Richard Stevens for his comments (1) on our recent article that showed no increased risk of breast cancer following recent night shift work when compared with recent day shift work (2). This finding was based on linkage of day-by-day info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dabdd1ed995d3819b43d641f4b9fabe8
https://pure.au.dk/portal/da/publications/response-to-dr-stevens-letter-ref-visitisen-et-al-shortterm-effects-of-night-shift-work-on-breast-cancer-risk-a-cohort-study-of-payroll-data(02373a0d-c846-41ce-b039-96693f7e3eb1).html
https://pure.au.dk/portal/da/publications/response-to-dr-stevens-letter-ref-visitisen-et-al-shortterm-effects-of-night-shift-work-on-breast-cancer-risk-a-cohort-study-of-payroll-data(02373a0d-c846-41ce-b039-96693f7e3eb1).html
Autor:
Bent Ejlertsen, Thomas P. Ahern, Uffe Heide-Jørgensen, Peer Christiansen, Deirdre P. Cronin-Fenton, Timothy L. Lash, Henrik Toft Sørensen
Publikováno v:
Cronin-Fenton, D P, Heide-Jørgensen, U, Ahern, T P, Lash, T L, Christiansen, P, Ejlertsen, B & Sørensen, H T 2016, ' Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence ', Epidemiology . https://doi.org/10.1097/EDE.0000000000000480
BACKGROUND: Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast